Literature DB >> 31578268

γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance.

Rafael M Rezende1, Brenda N Nakagaki2,3, Thais G Moreira2, Juliana R Lopes2, Chantal Kuhn2, Bruna K Tatematsu2, Selma Boulenouar2, Amir-Hadi Maghzi2, Stephen Rubino2, Gustavo B Menezes3, Tanuja Chitnis2, Howard L Weiner2.   

Abstract

Oral tolerance is defined as the specific suppression of cellular and/or humoral immune responses to an Ag by prior administration of the Ag through the oral route. Although the investigation of oral tolerance has classically involved Ag feeding, we have found that oral administration of anti-CD3 mAb induced tolerance through regulatory T (Treg) cell generation. However, the mechanisms underlying this effect remain unknown. In this study, we show that conventional but not plasmacytoid dendritic cells (DCs) are required for anti-CD3-induced oral tolerance. Moreover, oral anti-CD3 promotes XCL1 secretion by small intestine lamina propria γδ T cells that, in turn, induces tolerogenic XCR1+ DC migration to the mesenteric lymph node, where Treg cells are induced and oral tolerance is established. Consistent with this, TCRδ-/- mice did not develop oral tolerance upon oral administration of anti-CD3. However, XCL1 was not required for oral tolerance induced by fed Ags, indicating that a different mechanism underlies this effect. Accordingly, oral administration of anti-CD3 enhanced oral tolerance induced by fed MOG35-55 peptide, resulting in less severe experimental autoimmune encephalomyelitis, which was associated with decreased inflammatory immune cell infiltration in the CNS and increased Treg cells in the spleen. Thus, Treg cell induction by oral anti-CD3 is a consequence of the cross-talk between γδ T cells and tolerogenic DCs in the gut. Furthermore, anti-CD3 may serve as an adjuvant to enhance oral tolerance to fed Ags.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31578268      PMCID: PMC6832869          DOI: 10.4049/jimmunol.1900784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.

Authors:  R Förster; A Schubel; D Breitfeld; E Kremmer; I Renner-Müller; E Wolf; M Lipp
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

Review 2.  History and mechanisms of oral tolerance.

Authors:  Rafael M Rezende; Howard L Weiner
Journal:  Semin Immunol       Date:  2017-07-31       Impact factor: 11.130

3.  Oral anti-CD3 monoclonal antibody delays diabetes in non-obese diabetic (NOD) mice: effects on pregnancy and offspring--a preliminary report.

Authors:  Wendy C Bevier; Angelina L Trujillo; George B Primbs; Maia K Bradley; Lois Jovanovič
Journal:  Diabetes Metab Res Rev       Date:  2011-07       Impact factor: 4.876

4.  CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.

Authors:  L Chatenoud; J Primo; J F Bach
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.

Authors:  Melissa Swiecki; Susan Gilfillan; William Vermi; Yaming Wang; Marco Colonna
Journal:  Immunity       Date:  2010-12-02       Impact factor: 31.745

6.  Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

Authors:  Hirofumi Ochi; Michal Abraham; Hiroki Ishikawa; Dan Frenkel; Kaiyong Yang; Alexandre S Basso; Henry Wu; Mei-Ling Chen; Roopali Gandhi; Ariel Miller; Ruth Maron; Howard L Weiner
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

7.  Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.

Authors:  Hiroki Ishikawa; Hirofumi Ochi; Mei-Ling Chen; Dan Frenkel; Ruth Maron; Howard L Weiner
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

8.  Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells.

Authors:  H Y Wu; E M Center; G C Tsokos; H L Weiner
Journal:  Lupus       Date:  2009-06       Impact factor: 2.911

Review 9.  Cellular Components and Mechanisms of Oral Tolerance Induction.

Authors:  Rafael M Rezende; Howard L Weiner
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

10.  Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage.

Authors:  Matthew M Meredith; Kang Liu; Guillaume Darrasse-Jeze; Alice O Kamphorst; Heidi A Schreiber; Pierre Guermonprez; Juliana Idoyaga; Cheolho Cheong; Kai-Hui Yao; Rachel E Niec; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-05-21       Impact factor: 14.307

View more
  7 in total

1.  TRPS1 and YAP1 Regulate Cell Proliferation and Drug Resistance of Osteosarcoma via Competitively Binding to the Target of circTADA2A - miR-129-5p.

Authors:  Jinyu Zhang; Xiang Ma; Ruiqi Zhou; Yichi Zhou
Journal:  Onco Targets Ther       Date:  2020-12-01       Impact factor: 4.147

Review 2.  Role of orally induced regulatory T cells in immunotherapy and tolerance.

Authors:  Thais B Bertolini; Moanaro Biswas; Cox Terhorst; Henry Daniell; Roland W Herzog; Annie R Piñeros
Journal:  Cell Immunol       Date:  2020-11-14       Impact factor: 4.868

Review 3.  ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis.

Authors:  Đorđe Miljković; Bojan Jevtić; Ivana Stojanović; Mirjana Dimitrijević
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

4.  T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment.

Authors:  Bas D Koster; Marta López González; Mari Fcm van den Hout; Annelies W Turksma; Berbel Jr Sluijter; Barbara G Molenkamp; Paul Am van Leeuwen; Saskia Vosslamber; Rik J Scheper; Alfons Jm van den Eertwegh; M Petrousjka van den Tol; Ekaterina J Jordanova; Tanja D de Gruijl
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

5.  Traumatic brain injury in mice induces changes in the expression of the XCL1/XCR1 and XCL1/ITGA9 axes.

Authors:  Agata Ciechanowska; Katarzyna Popiolek-Barczyk; Katarzyna Ciapała; Katarzyna Pawlik; Marco Oggioni; Domenico Mercurio; Maria-Grazia de Simoni; Joanna Mika
Journal:  Pharmacol Rep       Date:  2020-11-13       Impact factor: 3.024

6.  Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis.

Authors:  Guillem Sanchez Sanchez; Maria Papadopoulou; Abdulkader Azouz; Yohannes Tafesse; Archita Mishra; Jerry K Y Chan; Yiping Fan; Isoline Verdebout; Silvana Porco; Frédérick Libert; Florent Ginhoux; Bart Vandekerckhove; Stanislas Goriely; David Vermijlen
Journal:  Nat Commun       Date:  2022-10-04       Impact factor: 17.694

Review 7.  The Role of Gamma-Delta T Cells in Diseases of the Central Nervous System.

Authors:  Jin Wo; Feng Zhang; Zhizhong Li; Chenghong Sun; Wencai Zhang; Guodong Sun
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.